Global HIV Treatment Gap Leaves 8.8 Million Behind
Global HIV treatment gap leaves 8.8 million people without therapy as funding cuts weaken testing, prevention and community-led services.
AI Alternatives To Animal Testing Gain Momentum
AI alternatives to animal testing can predict toxicity and organ damage while offering more ethical and human-relevant research methods.
US Prescription Drug Spending to Top $560bn in 2026
US prescription drug spending is forecast to exceed $560bn in 2026 as demand for GLP-1 obesity and diabetes treatments continues to rise.
iDexis Semaglutide Ban Ordered By High Court
iDexis semaglutide ban stops the pharmacy group from selling compounded weight-loss medicines while SAHPRA and the SAPC investigate.
SA’s PEPFAR Funding Faces US Withdrawal
SA’s PEPFAR funding could end as the FW de Klerk Foundation urges Donald Trump to protect vital HIV services and infrastructure.
Contraceptive Shortages Hit South African Healthcare
Contraceptive shortages hit South Africa following Aspen’s manufacturing issues, prompting alternatives for the public health sector.
Medical Scheme Clawbacks Upheld By High Court
Medical scheme clawbacks remain lawful after the High Court rejected a challenge to Section 59(3) of the Medical Schemes Act.
GEMS 2026 Contribution Increase Faces Regulatory Scrutiny
The GEMS 2026 contribution increase has repercussions for the public servants’ medical schemes amidst rising healthcare costs.
AI Healthcare Tools Cut South African Doctors’ Admin
AI Healthcare Tools are helping South African doctors reduce admin, improve clinical notes and free up more time for patient care.
European Drug-Pricing Policies Face Pushback From Big Pharma
Explore European drug-pricing policies and how they impact healthcare spending and patient access to life-saving medicines.